miR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma. - Wikidata - wikimedia - TriplyDB

miR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma.

miR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma.

http://www.wikidata.org/entity/Q54392168

about

MicroRNAs as Important Players and Biomarkers in Oral Carcinogenesis Nanotechnology in dentistry: prevention, diagnosis, and therapy Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies Semi-supervised learning for potential human microRNA-disease associations inference Clinical update on cancer: molecular oncology of head and neck cancer EGF up-regulates miR-31 through the C/EBPβ signal cascade in oral carcinoma.Prognostic role of microRNA-181a/b in hematological malignancies: a meta-analysis Up-regulated MicroRNA-181a induces carcinogenesis in hepatitis B virus-related hepatocellular carcinoma by targeting E2F5 Expression profiling analysis of the microRNA response of Cynoglossus semilaevis to Vibrio anguillarum and other stimuli.Interrelationships of circulating tumor cells with metastasis and thrombosis: role of microRNAs LEF1 targeting EMT in prostate cancer invasion is mediated by miR-181a.Small RNAs in metastatic and non-metastatic oral squamous cell carcinoma.TGF-β upregulates miR-181a expression to promote breast cancer metastasis.Contributions of microRNA dysregulation to cisplatin resistance in adenocarcinoma cells.MiR-487a Promotes TGF-β1-induced EMT, the Migration and Invasion of Breast Cancer Cells by Directly Targeting MAGI2.MicroRNA profiling of cisplatin-resistant oral squamous cell carcinoma cell lines enriched with cancer-stem-cell-like and epithelial-mesenchymal transition-type features.Investigation of the association between miR‑181b, Bcl‑2 and LRIG1 in oral verrucous carcinoma.microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition.Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia.Silencing the double-stranded RNA binding protein DGCR8 inhibits ovarian cancer cell proliferation, migration, and invasion.Recurrent genomic alterations in sequential progressive leukoplakia and oral cancer: drivers of oral tumorigenesis?Current trends in miRNAs and their relationship with oral squamous cell carcinoma.Circulating microRNAs in cancer: diagnostic and prognostic significance.Role of miRNA in head and neck squamous cell carcinoma.Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility.Non-coding RNAs deregulation in oral squamous cell carcinoma: advances and challenges.A comprehensive study of smoking-specific microRNA alterations in head and neck squamous cell carcinoma.Downregulation of microRNA-181d had suppressive effect on pancreatic cancer development through inverse regulation of KNAIN2.Improving accuracy of RNA-based diagnosis and prognosis of oral cancer by using noninvasive methods.Circulating miR-223 in Oral Cancer: Its Potential as a Novel Diagnostic Biomarker and Therapeutic Target.Characterization of miR-146a and miR-155 in blood, tissue and cell lines of head and neck squamous cell carcinoma patients and their impact on cell proliferation and migration.MicroRNA 181a improves proliferation and invasion, suppresses apoptosis of osteosarcoma cell.Downregulation of miR-544 in tissue, but not in serum, is a novel biomarker of malignant transformation in glioma.miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor.Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia.miRNAs: Important Targets for Oral Cancer Pain Research.Serum, plasma and saliva biomarkers for head and neck cancer.A Looking-Glass of Non-coding RNAs in oral cancer.MicroRNA-196a-5p is a potential prognostic marker of delayed lymph node metastasis in early-stage tongue squamous cell carcinoma.MiR-181 family-specific behavior in different cancers: a meta-analysis view.

P2860

Q26778591-22A03663-549A-40D9-A511-ED834E99481D Q26778689-3E38F609-3038-426D-946B-D43479616A85 Q26823077-6C6E2852-4D9B-4C6E-B835-98E0D2EE8ACF Q28656510-409315E3-6FE2-4B60-A9F4-6AFA077FCFDA Q33695197-B8B861FA-ECCD-4A5E-8434-A09F66117C0D Q34208077-1D757983-0941-4212-A5F9-EC85EA027E81 Q34637868-C086B3E0-63EE-4C43-B3F9-566A72E757C4 Q35094632-0481225E-DCBC-4A2F-B2C3-96332C6D3354 Q35567767-472CD495-A06C-46B1-9E0C-AC7F4808FFC3 Q35664886-246C31BB-FC1A-482D-98E6-E98C34C0F4B5 Q35666448-A904BE4B-249F-4D2E-9230-0CAF094767AF Q35672177-5100CBEE-9B7E-4811-A822-779EC2E28121 Q36497263-8E872A0C-28F1-4B32-87B9-7CBBBCD65F91 Q36585797-FA0C42BA-28AC-4EBB-BD20-976FF911F221 Q36727102-77EE8C35-D6CC-42EF-9C90-D78AB19E22F6 Q36764848-D291F94E-F90B-4972-8024-3AB64B8EF4A8 Q37297596-49C16678-E5CE-45C0-9EFB-10463A0DF62A Q37497239-126DF106-7741-41BB-8328-5F757D7DB229 Q37644854-23C7D268-26EF-41AB-8065-0D8F52897626 Q37699535-4D768D7F-92E7-40F9-84E8-D69528C79A32 Q37708370-5BC89E1A-EA5A-48BA-803D-538658D1A8C7 Q37970449-0B3851FC-C90F-4CAA-9157-DA4D4475E233 Q37982454-62BFE2BE-8057-4F42-818F-98D5260DDA3F Q38264776-522095CE-CA64-4079-967E-FA984FB6EFEA Q38321812-C06DD52F-6DBF-4CA4-B5CA-7A2F3655508E Q38586823-9D53745E-4A08-48D5-A992-76A2AADED480 Q38630118-A8E87824-E68E-4A0C-BE3C-17F90038B878 Q38708780-DF41ECBC-7A2F-4E94-830C-565FF8D5A19B Q38755836-33D8A65E-B388-4DC5-9C1E-2E7E4567AC25 Q38756678-1D475024-FE93-4E5E-BE82-B44A2486C331 Q38815624-ABDB2A8B-3080-4A32-86C8-60627A0072A8 Q39143458-2D3C680A-529F-4457-A7FA-13F3202E09BC Q42119044-28E77D63-CAA6-4581-8B12-53BB77663C6D Q44077666-1BFC7E56-6DC2-4CFC-8CFF-0B3CF4767C03 Q46040386-F066D3DD-9621-489F-91EF-DF0A2E3CB6C0 Q46902619-C8991C89-F82D-4B1B-A66C-BC7C4B84A1D4 Q47405806-F1095E43-7530-4CF6-AAF7-F8B35AA67F51 Q47800026-178DC40E-A382-477F-B6D7-21F940160406 Q49690867-A1BAC520-416B-4B7A-A904-BF7E37BC527E Q50073977-D0728899-3366-49B7-BEFC-B84AC825C062

P2860

miR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma.

http://www.wikidata.org/entity/Q54392168

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

miR-181 as a putative biomarke ...... oral squamous cell carcinoma.

@en

miR-181 as a putative biomarke ...... oral squamous cell carcinoma.

@nl

type

label

miR-181 as a putative biomarke ...... oral squamous cell carcinoma.

@en

miR-181 as a putative biomarke ...... oral squamous cell carcinoma.

@nl

prefLabel

miR-181 as a putative biomarke ...... oral squamous cell carcinoma.

@en

miR-181 as a putative biomarke ...... oral squamous cell carcinoma.

@nl

P1433

Q54392168-EF1DDC93-84F7-4B5F-B4A8-9D8C956922EE

P1476

Q54392168-2F84BE45-EAFE-4269-8998-C41B1393E464

P2093

Q54392168-0EDCF70D-EC2A-4B5C-943A-0302993E57C7

Q54392168-23868AA6-03F2-46F0-A8FA-0732CEAB0B6D

Q54392168-65522994-D568-4699-9D8A-3951D40C7327

Q54392168-8886B619-64B0-4B84-83BC-D5F2282A2342

Q54392168-8BA08A52-A613-4231-B7AE-008A098850B1

Q54392168-8FD561E5-7AF9-4BE5-9FDA-2BBC05FB2441

Q54392168-9114F231-D4BF-4D03-8E84-F225FBDD46E7

P2860

Q54392168-06A960E4-ABCC-4274-B12B-CE846A59F82D

Q54392168-0B0F6BBC-B006-4587-B09B-0212E3A90D1D

Q54392168-0E054E58-2D2D-49D6-813B-45EEF4A06BB4

Q54392168-122EDDE6-F20F-4E5C-832D-043E852A3CA2

Q54392168-145F1C74-A9B6-479C-A0F9-D6A944CB6A98

Q54392168-17552EAE-6622-4ED3-9703-F20DA5569824

Q54392168-1784CDDE-4EF2-465C-BE7F-80D20D75338A

Q54392168-1B6118B9-620B-4221-B130-D1ECD0A04BAE

Q54392168-1DC395E1-8EE9-4BCC-BFD5-1F517E61A7B7

Q54392168-262F74CD-D40A-4375-9529-9251D04B71C9

P304

Q54392168-E4DAA410-D3D2-4135-A46F-428096142E87

P31

Q54392168-E44C7E76-6445-4C92-A6D7-9A51075D82A0

P356

Q54392168-B17221BE-1D98-41B7-A325-A046F3E6040C

P433

Q54392168-FA97FD95-7BA2-4577-8646-8DFA986675D3

P478

Q54392168-212F2378-14D9-4E7C-94DC-32285FCED0E3

P577

Q54392168-FCACDB8E-CD85-4D28-B35B-B624AAD2D51E

P698

Q54392168-A0F29427-1250-413C-8594-55F774C712AB

P921

Q54392168-07ED61D9-9EEB-4965-98AD-64C0537D5DDF

Q54392168-E6632092-80BD-4F12-AAB6-BA0E69DAF392

P356

J.1600-0714.2010.01003.X

P1433

Journal of Oral Pathology & Medicine

P1476

miR-181 as a putative biomarke ...... oral squamous cell carcinoma.

@en

P2093

Cheng-Chieh Yang

http://www.w3.org/2001/XMLSchema#string

Chung-Ji Liu

http://www.w3.org/2001/XMLSchema#string

Hui-Wen Cheng

http://www.w3.org/2001/XMLSchema#string

Pei-Shih Hung

http://www.w3.org/2001/XMLSchema#string

Pei-Wen Wang

http://www.w3.org/2001/XMLSchema#string

Shu-Chun Lin

http://www.w3.org/2001/XMLSchema#string

Ting-Hui Chu

http://www.w3.org/2001/XMLSchema#string

P2860

Numerous microRNPs in neuronal cells containing novel microRNAs

Secretory mechanisms and intercellular transfer of microRNAs in living cells

MicroRNAs: target recognition and regulatory functions

MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1

Circulating microRNAs as stable blood-based markers for cancer detection.

Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells

CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control

MicroRNAs modulate hematopoietic lineage differentiation

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

MicroRNAs: genomics, biogenesis, mechanism, and function

P304

397-404

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1600-0714.2010.01003.X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21244495

http://www.w3.org/2001/XMLSchema#string

P921